Rises on positive data from COVID-19 test trial

Quotient

20/07/2020 15:36

** Shares of diagnostics company  QTNT.O  rise 4.8% to $8.69
    ** Independent study in Spain found co's diagnostic kit
demonstrated 100% ability to detect and 99.8% ability to rule
out the presence of COVID-19 antibodies  urn:newsml:reuters.com:*:nGNXc2H18Y 
    ** Test detects two types of antibodies produced in response
to SARS-CoV-2 infection - IgM and IgG antibodies
    ** The test, MosaiQ COVID-19 Antibody Microarray, passed EU
standards on May 1, 2020
    ** Stock down ~8.6% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))